Literature DB >> 34379435

Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Con Side of the Argument.

Ricky D Turgeon1, Andrew D Althouse2, Jordana B Cohen3, Bogdan Enache4,5, John B Hogenesch6, Michael E Johansen7, Raj Mehta8, Gideon Meyerowitz-Katz9, Boback Ziaeian10,11, Swapnil Hiremath12.   

Abstract

Entities:  

Keywords:  blood pressure; chronotherapy; circadian rhythm; clinical trial; epidemiology

Mesh：

Substances：

Year:  2021        PMID： 34379435      PMCID： PMC8363122          DOI： 10.1161/HYPERTENSIONAHA.121.16501

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


× No keyword cloud information.
  39 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis.

Authors:  Gil F Salles; Gianpaolo Reboldi; Robert H Fagard; Claudia R L Cardoso; Sante D Pierdomenico; Paolo Verdecchia; Kazuo Eguchi; Kazuomi Kario; Satoshi Hoshide; Jorge Polonia; Alejandro de la Sierra; Ramon C Hermida; Eamon Dolan; Eoin O'Brien; George C Roush
Journal:  Hypertension       Date:  2016-02-22       Impact factor: 10.190

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  [Evening dosing of antihypertensive drugs - future studies should be awaited before changing clinical practice].

Authors:  Mattias Brunström; Per Svensson
Journal:  Lakartidningen       Date:  2019-12-23

5.  Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project.

Authors:  Reinhold Kreutz; Sverre E Kjeldsen; Michel Burnier; Krzysztof Narkiewicz; Suzanne Oparil; Giuseppe Mancia
Journal:  Blood Press       Date:  2020-04-27       Impact factor: 2.835

6.  Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.

Authors:  Jamal S Rana; Grace H Tabada; Matthew D Solomon; Joan C Lo; Marc G Jaffe; Sue Hee Sung; Christie M Ballantyne; Alan S Go
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

7.  Characteristics and Outcomes of Retinal Artery Occlusion: Nationally Representative Data.

Authors:  Emily M Schorr; Kyle C Rossi; Laura K Stein; Brian L Park; Stanley Tuhrim; Mandip S Dhamoon
Journal:  Stroke       Date:  2020-01-17       Impact factor: 7.914

8.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

9.  Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.

Authors:  Ramón C Hermida; Juan J Crespo; Manuel Domínguez-Sardiña; Alfonso Otero; Ana Moyá; María T Ríos; Elvira Sineiro; María C Castiñeira; Pedro A Callejas; Lorenzo Pousa; José L Salgado; Carmen Durán; Juan J Sánchez; José R Fernández; Artemio Mojón; Diana E Ayala
Journal:  Eur Heart J       Date:  2020-12-21       Impact factor: 29.983

10.  Pharmacotherapy for hypertension in adults 60 years or older.

Authors:  Vijaya M Musini; Aaron M Tejani; Ken Bassett; Lorri Puil; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05
View more
  1 in total

1.  Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial.

Authors:  Scott R Garrison; Michael R Kolber; G Michael Allan; Jeffrey Bakal; Lee Green; Alexander Singer; Darryl R Trueman; Finlay A McAlister; Raj S Padwal; Michael D Hill; Braden Manns; Kimberlyn McGrail; Braden O'Neill; Michelle Greiver; Liesbeth S Froentjes; Donna P Manca; Dee Mangin; Sabrina T Wong; Cathy MacLean; Jessica Em Kirkwood; Rita McCracken; James P McCormack; Colleen Norris; Tina Korownyk
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.